Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance - Wikidata - awgldk - TriplyDB

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

http://www.wikidata.org/entity/Q34785741

about

Corticosteroids for the treatment of Kawasaki disease in children Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome Use of corticosteroids during acute phase of Kawasaki disease Can Coronary Artery Involvement in Kawasaki Disease be Predicted?Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease Immunoglobulin Resistance in Kawasaki Disease.Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response Corticosteroids for the treatment of Kawasaki disease in children.Establishment of Kawasaki disease database based on metadata standard Non-Responders to Intravenous Immunoglobulin and Coronary Artery Dilatation in Kawasaki Disease: Predictive Parameters in Korean Children The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.Management of Kawasaki disease.Management of acute and refractory Kawasaki disease.Kawasaki disease: pathophysiology, clinical manifestations, and management.Kawasaki disease: insights into pathogenesis and approaches to treatment.Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.Kawasaki disease and coronary artery aneurysms: from childhood to adulthood.Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores.Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.Dissecting Kawasaki disease: a state-of-the-art review.Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease.Effect and Safety of TNF Inhibitors in Immunoglobulin-Resistant Kawasaki Disease: a Meta-analysis.Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.Predicting IVIG resistance in UK Kawasaki disease.Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients Adjunctive therapies in Kawasaki disease.Verification of Current Risk Scores for Kawasaki Disease in Korean Children.One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.Role of intravenous immunoglobulin in the treatment of Kawasaki disease.

P2860

Q24194653-97F49B64-C5A0-4FF7-855B-F0EFE3A635FE Q26765479-685B232E-06EC-4482-8658-3FB38E866C1A Q26777190-9036640C-5C00-4E80-A64D-F745854BB5F3 Q26829091-67C4BEF1-46EA-4FA3-96D5-6B0979A3EBF9 Q33419638-03C42C9D-6761-4533-9697-5E1F417AF1ED Q33718985-D323334D-FA46-43F8-BD4B-CFE0C6668E35 Q35193974-BE3BE693-90ED-4976-A401-86F3318761F7 Q36240212-4A8086CD-6DDE-46CF-A8DB-7A0E848CE73C Q36262749-D9AE6155-442B-489C-979D-3254472857F5 Q37129983-5AEDD3CB-D29E-4269-A3C8-D841E4F45599 Q37136550-489E1FCD-B582-40D8-AC29-C19CDE2943DB Q37175810-BABA0780-63D3-466E-A381-7794EC1D2504 Q37465500-262A8D6F-6988-4536-84E8-0D2D7B920F3E Q38063969-A42689BA-F8E9-4304-8877-9FA4EC3CDB19 Q38205391-76BEE6ED-895B-4A7D-A75C-86FEFFA297F9 Q38439648-FB3958C2-A7E7-43DA-9DEB-042ED37E5F81 Q38546497-9F4E4AFC-000E-414A-A755-7106CD050082 Q38575942-4A39111C-B284-4D67-9B95-3122339F223F Q38638912-66E99FAB-40A1-4B64-8A28-0F4506AFFDEA Q38676515-2ADB6495-8918-4E1E-AA86-9A6C937D20F3 Q38719434-A88C6DD3-69DA-470D-80A9-5EE2AF74170D Q38828840-9F5DA015-05D2-4957-87BC-EB9B5F32F546 Q38842992-F2FF714D-2A36-47BF-A841-D95E8849FC70 Q38869612-F6E4D22E-2413-4C9E-AEE5-593FD565131F Q38993829-B0D8FB43-F358-4706-B5C4-5355BDF1F0D5 Q39401720-4175FCA5-774B-4D69-9BEA-0EC10AC2A845 Q40073906-8CB8F042-8749-4B36-A9AA-502A63C5A053 Q40091671-CE8F1A61-58D8-43FB-B49C-502EF54FEC84 Q40140080-6DB424C1-9D54-4E75-8003-8B391047B5D3 Q40500674-110F5A17-44BA-4821-8B1C-3E68E82688CC Q40740694-2E7F7D94-0D8A-4384-A7BE-5E63EEF4EC10 Q40803261-4ADCE203-895E-4A12-BCEB-9322F10AA944 Q41216033-00074CE8-FD5C-4C8A-B321-D37AAD3F390D Q41491226-6DF87852-ED29-4D0F-BDFA-1F63EB838DE9 Q42678825-09CE1272-E06E-4081-8F4D-05D790A82408 Q45161770-643E9382-9B0D-406E-98E3-6D491683460C Q45978588-ACBB828B-3E28-4CD8-809E-672DA01E0825 Q46162638-BCF0CF53-BE8B-4EF5-9DD1-A82749E1807E Q47182586-B585767D-E3A2-467D-BD72-06D3D8A6E636 Q50071875-94ADD5D4-781F-4D94-9987-EF42D52EF9C5

P2860

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

http://www.wikidata.org/entity/Q34785741

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@ast

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@en

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@nl

type

label

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@ast

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@en

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@nl

prefLabel

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@ast

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@en

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@nl

P1433

Q34785741-40CEB00A-F0D3-4188-865F-FADEC45259D9

P1476

Q34785741-F871BD57-DE78-41C8-A1B3-12B393C95F32

P2093

Q34785741-50EF2F2B-D7AA-4715-B6B3-DF5B10C87916

Q34785741-647934F5-F66A-464A-94DE-CCE7430BBDEB

Q34785741-678C2789-BE81-4C93-873E-50C58EBA69E3

Q34785741-7BE2E84B-E4C9-4CA1-96B1-66B8DF7482AD

Q34785741-7D7FEE79-0616-47FA-A865-BDBADB1B3EF5

Q34785741-8712BDAE-26DF-4215-B3A0-1EE84CDE8B2C

Q34785741-980FC449-07F4-44A6-8004-7EB2CF6BBA58

Q34785741-D687C27F-5A88-439F-B6CB-02D37BCFCB75

Q34785741-E7B968C7-BC8A-45A5-81DC-47FDC4BFFD72

Q34785741-EEFCF958-DFD7-4E40-92FE-4F779DB42301

P2860

Q34785741-5068BE42-A29E-4676-8A45-54CD9403F185

Q34785741-65BAD8D2-1EDE-4063-A153-F0267EE3A96B

Q34785741-968826FA-AC5E-4FD4-92C7-DEA328B04B22

Q34785741-A136B2CC-FE40-4EA9-A918-23B2943EB147

Q34785741-A18FA43D-C5B8-4AC5-B2BB-F834B01A3F32

Q34785741-A4ABDCE7-AF8A-4F34-BBD0-DF34983EDEF2

Q34785741-A9BB1888-65B9-4760-9C27-5A7B44782EE6

Q34785741-AA00D798-2737-4302-B0C6-8985AE4390BC

P304

Q34785741-7B643466-84E7-4888-8F45-0329093517B5

P31

Q34785741-8CE523AD-37C6-4C27-B368-A1706F3EF050

P356

Q34785741-81C2A98E-E6CF-49C3-8EB9-3C36F4AD9F3C

P407

Q34785741-60C42E03-85CE-4C92-9A45-A8E81F0D02BE

P433

Q34785741-75EDF335-0AC3-4436-BC08-B79568829F52

P478

Q34785741-F8A01679-D148-4855-B93C-F33CD0A92023

P50

Q34785741-1FC6B26F-BC4B-4B09-9B4E-295F55851E1D

Q34785741-97C8C4E3-229F-4CB8-B0A0-8D6430DC928D

P577

Q34785741-046038FE-8E28-4F3D-803D-A640E76FCE2F

P5875

Q34785741-24040BC5-F7BA-4CD4-BCAC-6248FC7917BE

P698

Q34785741-7C147559-CB3D-4FA0-97C4-0FD056DDD994

P932

Q34785741-B41B1041-8E78-4B25-9BEE-948D0F541530

P356

J.JPEDS.2010.10.031

P1433

The Journal of Pediatrics

P1476

Evaluation of Kawasaki disease ...... nous immunoglobulin resistance

@en

P2093

Andrew M Atz

http://www.w3.org/2001/XMLSchema#string

Annette Baker

http://www.w3.org/2001/XMLSchema#string

Beth F Printz

http://www.w3.org/2001/XMLSchema#string

Brian M McCrindle

http://www.w3.org/2001/XMLSchema#string

Jennifer S Li

http://www.w3.org/2001/XMLSchema#string

L Luann Minich

http://www.w3.org/2001/XMLSchema#string

Lynn A Sleeper

http://www.w3.org/2001/XMLSchema#string

Steven D Colan

http://www.w3.org/2001/XMLSchema#string

Victoria L Vetter

http://www.w3.org/2001/XMLSchema#string

Wilbert Mason

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, treatment, and long-term management of Kawasaki disease

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

Resistance to intravenous immunoglobulin in children with Kawasaki disease

Risk factors for nonresponse to therapy in Kawasaki disease.

Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature.

Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.

P304

831-835.e3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPEDS.2010.10.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

Jane W. Newburger

Pediatric Heart Network Investigators

P577

2010-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49693566

http://www.w3.org/2001/XMLSchema#string

P698

21168857

http://www.w3.org/2001/XMLSchema#string

P932

3075321

http://www.w3.org/2001/XMLSchema#string